Trend in Number of Phase III Trials Initiated from 2021 to 2023

Exploring the fluctuating trend in Phase III clinical trials over three years

__timestampPhase III Trials Count
Friday, January 1, 2021192
Monday, February 1, 2021166
Monday, March 1, 2021213
Thursday, April 1, 2021203
Saturday, May 1, 2021163
Tuesday, June 1, 2021218
Thursday, July 1, 2021166
Sunday, August 1, 2021167
Wednesday, September 1, 2021196
Friday, October 1, 2021181
Monday, November 1, 2021175
Wednesday, December 1, 2021188
Saturday, January 1, 2022177
Tuesday, February 1, 2022149
Tuesday, March 1, 2022183
Friday, April 1, 2022161
Sunday, May 1, 2022149
Wednesday, June 1, 2022182
Friday, July 1, 2022137
Monday, August 1, 2022162
Thursday, September 1, 2022154
Saturday, October 1, 2022145
Tuesday, November 1, 2022159
Thursday, December 1, 2022163
Sunday, January 1, 2023180
Wednesday, February 1, 2023140
Wednesday, March 1, 2023188
Saturday, April 1, 2023144
Monday, May 1, 2023149
Thursday, June 1, 2023148
Saturday, July 1, 2023142
Tuesday, August 1, 2023158
Friday, September 1, 2023135
Sunday, October 1, 2023151
Wednesday, November 1, 2023180
Friday, December 1, 2023185
Loading chart...

Data in motion

In the past three years, the number of Phase III clinical trials initiated has shown a fluctuating trend. Starting strong in January 2021 with 192 trials, the count dipped to 137 in July 2022 before picking up again. The peak of 218 trials was reached in June 2021. Despite some variability, the overall trend seems to be stable, with an average of 168 trials per month. However, it's important to note that there are missing values in the dataset, which could potentially impact the accuracy of the trend analysis. As the field of clinical trials continues to evolve, these insights provide valuable information for researchers and stakeholders.

00

Date published
20 Jun 2024